Teamwork Financial Advisors LLC Trims Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Teamwork Financial Advisors LLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 15.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,657 shares of the biotechnology company's stock after selling 1,263 shares during the quarter. Teamwork Financial Advisors LLC's holdings in Axon Enterprise were worth $3,501,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Capital World Investors lifted its position in shares of Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after purchasing an additional 841,772 shares during the last quarter. Alliancebernstein L.P. grew its holdings in shares of Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Norges Bank purchased a new position in Axon Enterprise in the 4th quarter worth about $482,081,000. GQG Partners LLC bought a new stake in Axon Enterprise during the 4th quarter valued at about $478,349,000. Finally, GAMMA Investing LLC boosted its position in Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock valued at $402,210,000 after buying an additional 763,431 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AXON has been the topic of a number of research reports. Bank of America raised their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Barclays lifted their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. The Goldman Sachs Group increased their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Finally, Needham & Company LLC raised their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Stock Up 0.9%

Shares of NASDAQ AXON traded up $7.40 during mid-day trading on Friday, reaching $795.76. 262,554 shares of the company were exchanged, compared to its average volume of 729,755. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $61.95 billion, a price-to-earnings ratio of 205.62, a P/E/G ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a 1 year low of $278.24 and a 1 year high of $798.16. The firm has a 50-day moving average of $638.88 and a 200 day moving average of $615.19.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the previous year, the business posted $1.15 EPS. Axon Enterprise's revenue was up 31.3% on a year-over-year basis. On average, research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael Garnreiter sold 87 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $760.00, for a total transaction of $66,120.00. Following the completion of the sale, the director now owns 24,653 shares of the company's stock, valued at $18,736,280. This trade represents a 0.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,969 shares of company stock worth $29,909,594. 4.40% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.